Detection of plasmid-mediated AmpC β-lactamase in Escherichia coli

Escherichia coli (E. coli) is a common opportunistic pathogen for nosocomial infection. The aim of the study was to examine the phenotype, genotype and epidemiology of plasmid‑mediated AmpC β‑lactamases in E. coli. In total, 96 clinical isolates of repeated E. coli were collected from different hospitals between August and October 2012. Using a cefoxitin disk diffusion method to identify the phenotype of AmpC β‑lactamases in E. coli, the plasmid was extracted, and multiplex polymerase chain reaction (PCR) was used to determine the amp gene. The PCR products were purified and sequenced. Of the 96 isolates strains, 43 strains were cefoxitin‑resistant. Twelve (12.5%) isolates were detected to produce AmpC β‑lactamases with multiplex PCR, 11 strains carried DHA type ampC‑resistant genes, and one strain carried ACC type ampC‑resistant genes. In conclusion, the incidence of producing a plasmid‑mediated AmpC enzyme of E. coli strains was relatively high. Therefore, antibiotics such as imipenem, a carbapenem, potentially serve as the treatment of choice for the infection.